Overweight and obesity versus concentrations of VEGF-A, sVEGFR-1, and sVEGFR-2 in plasma of patients with lower limb chronic ischemia

Abstract

Objective: Being overweight or obese comprises a significant risk factor for atherosclerosis. Fat tissue also generates factors stimulating angiogenesis, the process by which new blood vessels form. The purpose of this paper is to assess concentrations of the vascular endothelial growth factor A (VEGF-A) and its soluble type-1 and type-2 receptors (sVEGFR-1 and sVEGFR-2) in plasma of patients with peripheral arterial disease (PAD) depending on the level of nutrition according to body mass index (BMI). Methods: The study group included patients suffering from symptomatic PAD (n=46) in Fontaine classes IIa-IV without any history of neoplastic disease and who have a normal BMI (n=15), are overweight (n=21) or are obese (n=10). The control group (n=30) consisted of healthy non-smoking volunteers who were neither overweight nor obese. Venous blood plasma samples were collected from both groups at rest in the morning to determine plasma concentrations of VEGF-A, sVEGFR-1, and sVEGFR-2 using the enzymelinked immunosorbent assay (ELISA) method. Results: The group of patients with PAD co-existent with being overweight or obese tended to have higher mean concentration levels of VEGF-A and sVEGFR-2 when compared with patients suffering from PAD with normal BMI. A statistically significant positive correlation was obtained between BMI and average plasma concentrations of sVEGFR-2 (R=0.37, P=0.0103). However, no significant correlation was noticed between BMI and VEGF-A or sVEGFR-1 concentrations. Conclusions: A positive correlation determined between the level of antiangiogenic factor and BMI value may be indicative of the linearly growing prevalence of some antiangiogenic factors in patients with metabolic disorders, which may be one of numerous factors contributing to incomplete efficiency of collateral circulation development in patients with PAD.

Intramuscular diclofenac is a cause of Nicolau syndrome in obese women: An observational study of consecutive ten patients

“…Obesity is defined as body mass index (BMI) of more than 30. Since it is closely related to atherosclerosis so the deterioration of microvascular circulation, it carries a major risk for thromboembolic events 5 . Indeed, women are more likely to be obese than men 6 .…”

The association of vascular endothelial growth factor related SNPs and circulating iron levels might depend on body mass index

“…VEGF is involved in the pathogenesis of obesity [26]. Being an endocrine organ, the fat tissue releases significant amounts of VEGF, inducing angiogenesis [26,27]. Plasma VEGF was detected in significantly higher amounts in obese people than normal weight and lean subjects [26].…”

Angiogenesis system, as a part of endothelial dysfunction in patients with diabetes mellitus type 2: relationship with obesity

“…В работе R. Wieczór и соавт. предположили, что жировые клетки и/или ЭК, количество которых увеличивается при нарастании массы тела, вероятно, являются основным источником растворимой формы рецептора KDR [19].…”